Call us today at (978) 358-7307, or just click here:
By now, you’ve likely encountered discussions surrounding the EU Medical Device Regulation (EU MDR) and the EU In-Vitro Diagnostic Regulation (EU IVDR). These regulations represent a significant shift in the European regulatory framework, introducing more rigorous requirements for medical devices and in-vitro diagnostics to ensure patient safety, product transparency, and post-market surveillance.
The EU MDR, effective May 26, 2021, and the EU IVDR, effective May 26, 2022, have fundamentally reshaped the compliance landscape. All manufacturers wishing to place their devices on the European market must now fully adhere to these updated regulations.
While approximately 65% of the EU IVDR requirements overlap with the older In-Vitro Diagnostic Directive (IVDD), the IVDR is far more prescriptive. It specifies not just what evidence is required but also how it must be presented and justified.
For example:
With deep expertise in EU regulatory frameworks and a team experienced in working directly with Notified Bodies, RQMIS offers tailored strategies to:
Don’t let the complexity of the EU MDR and IVDR slow your progress. Partner with RQMIS to navigate these regulations confidently, ensuring compliance, patient safety, and market success.
Call us today at (978) 358-7307, or just click here: